Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Ravitsemuksen optimointi ja yhteisön kohottaminen synnytyksen jälkeiseen palautumiseen (NOURISH-GDM)

torstai 17. syyskuuta 2026 päivittänyt: Johns Hopkins University

Ravitsemuksen optimointi ja yhteisön kohottaminen synnytyksen jälkeiseen toipumiseen: Interventiot raskausdiabeteksen jälkeisen paranemisen tukemiseksi

The goal of this clinical trial is to better understand how different strategies, timing, and enhancements to medically tailored food delivery will address structural inequities in the food environment, empower communities to sustain behavior change, and ultimately improve postpartum weight control to prevent type 2 diabetes-a potent contributor to disparate mortality among Black women.

The main aims of the study are:

  • To conduct a pilot randomized control trial to test the feasibility, acceptability, and effectiveness of a multi-component Medically Tailored Food (MTF) intervention, Moveable Feast ENHANCED (a hybrid MTF intervention with a patient-activated change from prepared meals to fresh food delivery, customized for postpartum people, culturally customized for engagement and adherence, and food provision for dependents) versus MFeast Usual Care (prepared medically tailored foods only)
  • To test sustainability and scalability.

Participants will:

  • Respond to online surveys (supported by study team members via scheduled phone calls) via REDCap links shared before each study visit at baseline, 3, 6 months post-delivery after the baseline survey.
  • Submit anthropometric data (i.e, weight) and information about laboratory results ( e.g. HgbA1C)

Tutkimuksen yleiskatsaus

Yksityiskohtainen kuvaus

This study will evaluate the feasibility, acceptability, and preliminary effectiveness of a postpartum dietary intervention for Black women with obesity and a recent pregnancy complicated by gestational diabetes mellitus (GDM). The investigators will recruit women through Medicaid insurance plans (Priority Partners), clinical obstetric practice (Johns Hopkins Outpatient Center, Women's Health Center), perinatal community-based organizations (MOM Cares and Bloom Collective), and home-visiting locations (The Family Tree of Maryland)-all of which can verify clinical outcomes for participants.

At 37 weeks gestation, participants are contacted by the study team for consent, baseline data collection (baseline visit 1), and randomization 1:1 to receive the intervention vs. usual care (which begins in the first postpartum week). 3-7 days after randomization, the remainder of baseline visit information (baseline visit 2) is collected including information for the prepared MTF vendor (Moveable Feast Baltimore)

The intervention group will initially receive prepared MTF (low carbohydrate, and low-fat meals, which have been shown to improve glycemia in people with prediabetes) delivered by Moveable Feast (MFeast) (10 meals weekly; Tailored Medical Nutrition Therapy (MNT) delivered by dieticians from MFeast via monthly phone calls and focused on two high yield topics only: ↓sugar-sweetened beverages and ↑ fruit and vegetable consumption; Lactation nutritional snack bundles to boost milk supply + structural support for breastfeeding/ pumping via lactation consultants and pumping supply subsidization; culturally-adapted seasoning bundles; and dependent meal boxes for children in the household (i.e., will include 10 developmentally appropriate snack and small meal bundles, for up to 24 weeks. At postpartum week 8, participants will be offered a transition from prepared medically tailored meals to Instacart fresh food delivery (medically tailored via study team-crafted virtual grocery store) for 16 more weeks.

Those assigned to the "MFeast Usual Care" group will receive prepared MTF delivered by MFeast and as-needed MNT from 1 to 24 weeks postpartum.

Opintotyyppi

Interventio

Ilmoittautuminen (Arvioitu)

40

Vaihe

  • Ei sovellettavissa

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskeluyhteys

  • Nimi: Michelle S Ogunwole, MD PhD
  • Puhelinnumero: 2143154936
  • Sähköposti: sogunwo1@jhmi.edu

Opiskelupaikat

    • Maryland
      • Baltimore, Maryland, Yhdysvallat, 21205
        • Rekrytointi
        • East Baltimore Medical Campus

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

18 vuotta ja vanhemmat (Aikuinen, Vanhempi Aikuinen)

Hyväksyy terveitä vapaaehtoisia

Ei

Sukupuolet, jotka voivat opiskella

Nainen

Kuvaus

Inclusion Criteria:

  • Age ≥18 years
  • Self-identify as Black or African American
  • Low-income (defined as eligible for Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) benefits)
  • Speak English as a primary language
  • Identify as a primary meal planner/preparer
  • Gestational diabetes
  • Gestational age >37 weeks
  • Have a BMI > 30 (calculated based on chart review of height and weight measurement)
  • Willing to take part in the intervention and data collection procedures through online surveys

Exclusion Criteria:

  • Mothers who have social support i.e. have family members preparing meals for the mother
  • Mothers who are unlikely to be at the primary residence in the postpartum period
  • Mothers with very specific dietary needs, i.e, food allergies, picky eaters, vegetarian / vegan
  • Mothers whose birth outcome is a stillborn
  • Mothers who have serious mental illness

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Ennaltaehkäisy
  • Jako: Satunnaistettu
  • Inventiomalli: Rinnakkaistehtävä
  • Naamiointi: Yksittäinen

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Kokeellinen: MFeast ENHANCED

MFeast ENHANCED (a hybrid MTF intervention with a patient-activated transition from prepared meal to fresh food delivery, adaptations for postpartum people, structural and nutritional lactation support, cultural adaptations for engagement and adherence, and food provision for dependents)

Intervention group will initially receive prepared MTF (low carbohydrate, low-fat meals, which have been shown to improve glycemia in people with prediabetes) delivered by MFeast (10 meals weekly); Tailored Medical Nutrition Therapy (MNT) delivered by dieticians from MFeast via monthly phone calls and focused on only: ↓sugar-sweetened beverages and ↑fruit and vegetable consumption; Lactation snack bundles to boost milk supply + structural support for breastfeeding/pumping via lactation consultants and pumping supply subsidization; culturally-adapted seasoning bundles; and dependent meal boxes for children in the household (i.e., will include 10 developmentally appropriate snack and small meal bundles, for up to 24 weeks. At postpartum week 8 participants will be offered a transition from prepared medically tailored meals to Instacart fresh food delivery (via study team-crafted virtual grocery store) for 16 more weeks.

Active Comparator: MFeast Usual Care

MFeast Usual Care (prepared medically tailored meals only).

Those assigned to the "MFeast Usual Care" group will receive prepared MTF delivered by MFeast and as needed MNT from 1 to 24 weeks postpartum.

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Participant Enrollment Rate
Aikaikkuna: 6-8 months postpartum

Participant Enrollment Rate as assessed by the percentage of participants consented/enrolled compared to the total eligible participants

6-8 months postpartum
Participant Retention
Aikaikkuna: 6-8 months postpartum

Retention as assessed by the percentage of participants completing all study follow-up visits among all enrolled participants.

6-8 months postpartum
Adherence as assessed by self-reported food consumption scores and photographs sent to the study team via secure messaging app
Aikaikkuna: 6-8 months postpartum

Consumption scores range from 0%, 25%, 50%, 75%, or 100%, indicating the amount of food consumed the prior week (self and dependents scores reported).

6-8 months postpartum
Satisfaction as assessed by focus groups and the 8 item Client Satisfaction Questionnaire- (CSQ-8)
Aikaikkuna: 6-8 months postpartum

Participants rate satisfaction with the intervention's meal quality, delivery service, and likelihood of recommending the service to others at study completion, to assess the extent to which the intervention met their needs and preferences. Scores range from 8 to 32, with higher values indicating higher satisfaction.

6-8 months postpartum
Participant Engagement assessed by frequency and quality of meal discussions
Aikaikkuna: 1-6 months postpartum

Analyze the messaging app and Slack Channel to determine the frequency and quality of discussions about meals and recipes.

1-6 months postpartum

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Dietary Quality as assessed by the Healthy Eating Index (HEI) 24-hour recall
Aikaikkuna: Baseline, 3 and 6 months postpartum

The HEI uses a scoring system to evaluate a set of foods. The scores range from 0 to 100. An ideal overall HEI score of 100 reflects that the set of foods aligns with key dietary recommendations and dietary patterns published in the Dietary Guidelines.

Baseline, 3 and 6 months postpartum
Stress assessed by the 4-item Stress Scale.
Aikaikkuna: Baseline, 3 and 6 months postpartum

The 4-item Stress Scale consists of 4 questions. The lowest total score is 0 and the highest total score on the scale is 16. Higher scores are correlated to more stress.

Baseline, 3 and 6 months postpartum
Food Insecurity measured using a 6-item Food Insecurity scale.
Aikaikkuna: Baseline, 3 and 6 months postpartum

The 6-item Food Insecurity scale uses a subset of the standard 18 item food security scale. The Scores on the scale range from 0-6 with 0-1 indicating high or marginal food security, 2-4 indicating low food security and 5-6 indicating very low food security

Baseline, 3 and 6 months postpartum
Postpartum Weight Retention in pounds as assessed by the difference in self-reported pre-pregnancy weight and postpartum weights
Aikaikkuna: Baseline, 3 and 6 months postpartum

Will be assessed by calculating the difference in self reported pre-pregnancy weight (with Electronic Health Record validation) and postpartum weights (study provided scales)

Baseline, 3 and 6 months postpartum

Muut tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
2 hour plasma glucose levels assessed using Oral Glucose Tolerance Test (OGTT)
Aikaikkuna: 4-12 weeks postpartum

Test will be done using 75 g oral glucose load with measurement of 2-hour plasma glucose levels. Obtained by electronic health records (EHR) or lab request.

4-12 weeks postpartum
HbA1C
Aikaikkuna: 3 and 6 months postpartum

HbA1C assessed by EHR or lab request

3 and 6 months postpartum
Percent time spent in euglycemia as assessed by participant blinded Continuous Glucose Monitor (CGM) sensor
Aikaikkuna: 3 and 6 months postpartum

Will be measured by % time in euglycemia (glucose 70-139)

3 and 6 months postpartum
Percent time spent in hyperglycemia assessed by participant blinded CGM sensor
Aikaikkuna: 3 and 6 months postpartum

Will be measured by % time with hyperglycemia (glucose >140)

3 and 6 months postpartum
Postprandial glucose excursions assessed by participant blinded CGM sensor
Aikaikkuna: 3 and 6 months postpartum

Postprandial glucose is calculated using the incremental area under the curve (AUCi) of blood glucose (mg/dL) over a period of time. The AUCi will be calculated for 1 hour (AUCi 0-60) after a meal. The participants will have the sensors on for 10 days, and will be asked to document their meals to correlate with calculated AUCi's.

3 and 6 months postpartum
Mean daily glucose
Aikaikkuna: 3 and 6 months postpartum

Mean daily glucose for 10 days in months 3 and 6 postpartum

3 and 6 months postpartum

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Tutkijat

  • Päätutkija: Michelle S Ogunwole, MD, PhD, Johns Hopkins School of Medicine

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Todellinen)

Maanantai 15. syyskuuta 2025

Ensisijainen valmistuminen (Arvioitu)

Maanantai 1. maaliskuuta 2027

Opintojen valmistuminen (Arvioitu)

Tiistai 1. kesäkuuta 2027

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Perjantai 31. toukokuuta 2024

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Perjantai 31. toukokuuta 2024

Ensimmäinen Lähetetty (Todellinen)

Torstai 6. kesäkuuta 2024

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Tiistai 22. syyskuuta 2026

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Torstai 17. syyskuuta 2026

Viimeksi vahvistettu

Tiistai 1. syyskuuta 2026

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa